Power Training for Sarcopenic Obesity: What One Trial Found

For older women with sarcopenic obesity, a 32-week program that progressed from conventional resistance work to high-speed resistance training reversed the study's composite diagnosis in 35.7% of affected participants. That is a notable result, but it comes from one assessor-blinded, cluster-randomized trial in Spain—not a new universal exercise prescription.

The trial also offers a useful, narrower comparison with multicomponent training. High-speed resistance training produced better mobility and waist-circumference results; multicomponent training produced better performance on an aerobic step test. Exercise choice should follow the outcome that matters most, rather than treating "power training" as a magic word with unusually good branding.

What the 32-week trial actually tested

Polo-Ferrero et al.'s 2025 randomized clinical trial enrolled 120 community-dwelling women with probable sarcopenia, with a mean age of 77.0 years. Community centers, rather than individual participants, were randomized. The power-training arm began with 11 weeks of traditional resistance training, then completed 21 weeks of progressively high-speed resistance training. This sequence matters: participants built tolerance for resistance exercise before being asked to move the concentric phase as fast as possible.

Among participants who met both EWGSOP2 sarcopenia criteria and ESPEN obesity criteria at baseline, 35.7% in the power-training group no longer met both criteria after the intervention. The endpoint required simultaneous normalization of the study's sarcopenia and obesity definitions. It is more demanding than an improvement in grip strength, a smaller waist, or a favorable body-composition change alone.

Still, the study did not report the corresponding sarcopenic-obesity reversal rate for the multicomponent-training arm. That prevents a direct claim that power training beat multicomponent training on this composite endpoint. The result shows that the periodized program achieved reversal in some affected women; it does not establish that no other exercise program could do the same.

Sarcopenic obesity combines low muscle function or mass with excess adiposity, a combination linked to cardiovascular risk and functional decline in older adults. A systematic review by Evans et al. describes why this diagnosis carries more clinical weight than a body-composition label alone.

Where high-speed resistance training did better

A parallel report from the same trial compared the full cohort's functional and body-composition outcomes across high-speed resistance training, multicomponent training, and a non-exercise control. These are not independent confirmations: the participants and randomization were the same.

In the Gerontology report, high-speed resistance training outperformed multicomponent training on the Timed Up and Go test by 0.9 ± 1.9 seconds (p=.007) and on waist circumference by 4.5 ± 5.1 cm (p=.010). The reported p values indicate statistically significant between-group differences, but the publication details provided here do not include confidence intervals, so their precision cannot be assessed from those figures alone.

Those results fit the program's design. Fast concentric resistance movements train the ability to generate force quickly, which may matter for standing, turning, and recovering balance during everyday movement. The waist result occurred without a dietary intervention. The trial cannot show whether it arose through energy expenditure, changes in muscle metabolism, altered eating, or another pathway.

Both exercise programs improved five-times-sit-to-stand performance relative to the non-exercise control: −3.2 ± 2.5 seconds with high-speed resistance training and −2.6 ± 2.5 seconds with multicomponent training. The difference between the two exercise groups was not statistically significant (p=.127). For this outcome, either program was a reasonable choice.

Multicomponent training kept its aerobic advantage

Multicomponent training was not the losing arm in every contest. It improved the 2-minute step test by 19.9 ± 17.2 steps more than high-speed resistance training (p=.044). Because multicomponent programs preserve an aerobic component, this advantage is plausible, but the trial measured performance rather than proving a physiological mechanism.

This distinction matters for real-world programming. An older adult whose priority is walking tolerance, cardiorespiratory fitness, or readiness for a long trip may benefit more from a program that includes aerobic work. Someone focused on mobility, rapid force production, or central adiposity may reasonably prioritize the periodized power approach—provided qualified supervision and appropriate screening are available.

Must power training use heavy loads?

The answer appears to be no for maximal power output in general older-adult samples, although the evidence remains thin. A 2023 systematic review and meta-analysis by Bandeira-Guimarães et al. pooled three randomized trials, with PEDro quality scores of 6 to 8. Protocols using low-to-moderate loads (≤69% of one-repetition maximum) produced statistically equivalent gains in maximal power output to protocols using high loads (≥70% 1RM). High-load training showed a non-significant trend toward greater maximal-strength gains in single-joint exercises.

That finding supports a practical principle: move the lifting phase with maximal intended speed, while choosing loads that fit the person's joints, skill, and confidence. It does not prove that lighter loading works equally well in sarcopenic obesity. None of the three trials in that meta-analysis studied that metabolically impaired subgroup, and three trials provide limited power to detect moderate differences.

An RCT by Lindberg et al. adds related evidence in older men: training individualized to a person's force-velocity profile improved physical function more than standardized training. It supports individualized prescription, but it did not study women with sarcopenic obesity and cannot validate the Spanish trial's protocol in a different population.

Why standard resistance training and nutrition still belong in the conversation

Power training is not uniquely necessary for every sarcopenia endpoint. A 2026 meta-analysis of conventional resistance training in older women with sarcopenia found significant improvements in muscle mass, strength, and physical function, with standardized mean differences of roughly 0.4 to 0.6. It addressed sarcopenia, not necessarily sarcopenic obesity, and did not test maximal-velocity execution. Its results nevertheless weaken any claim that conventional resistance training has become obsolete.

Nutrition is another major omission from the central trial. An umbrella review by Reiter et al. and a 2025 meta-analysis in older women with sarcopenic obesity found that combined exercise and nutrition interventions outperform exercise alone for body-composition outcomes. That does not mean adding protein would necessarily raise the 35.7% reversal rate under this exact protocol; the necessary head-to-head trial has not been done.

The question is especially relevant because obesity and metabolic disease can blunt anabolic responses to protein supplementation and conventional resistance exercise in older adults, according to a 2025 retrospective analysis by Nilsson et al.. Whether high-speed resistance training overcomes that resistance remains unknown.

Limits that should shape the prescription

• The central result rests on one trial, and its cluster randomization by community center can introduce differences in instructors, facilities, or group dynamics between study arms.
• All participants were women from one Spanish geriatric revitalization program. The findings do not establish comparable effects in men, other populations, or adults over 80.
• Participants had to attend at least 85% of sessions for inclusion. This makes the result less informative about adherence in ordinary practice. Available reporting also does not quantify participant-level injury rates, specific adverse events, or dropout reasons.
• There was no post-intervention follow-up. A study in older adults with COPD found functional decline after a power-training-plus-HIIT program ended, but that population and program differ from this trial. It is a reason to plan maintenance exercise, not proof that these women would lose their gains at the same rate.
• The reversal endpoint depends on EWGSOP2 and ESPEN diagnostic cut-points. Different sarcopenia and obesity definitions could classify the same participant differently.

The practical verdict

For an older woman with confirmed or probable sarcopenic obesity, a supervised 32-week progression from conventional resistance training to high-speed resistance work is an evidence-based option when the priorities are mobility and waist circumference. It achieved composite sarcopenic-obesity reversal in 35.7% of affected participants in one trial, and it beat multicomponent training on Timed Up and Go and waist circumference in that same trial.

Choose multicomponent training when aerobic capacity is the main target. Choose conventional resistance training when it is the feasible, sustainable option; it has substantial support for sarcopenia outcomes. For power work, lighter loads may be appropriate when high loads are poorly tolerated, as long as the person can move safely with fast intent. The most defensible plan also includes nutrition assessment and a maintenance strategy, because the trial answered what happened over 32 weeks—not what happens after the classes stop.